# Anbio Biotechnology (NNNN)

> Source: Nexqual · https://nexqual.com/NNNN · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Anbio Biotechnology (NNNN), nexqual.com/NNNN" · informational, not investment advice.

**Price:** USD 3.3 (-7.56% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 3.57 · day 3.09–3.7 · 52w 3.09–44.73 · market cap $145M · NGM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -88.1% vs S&P 500 +18.1%; 5Y -42.8% vs S&P 500 +85.1%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2025-02-17) |
|---|---|---|
| Total return | -88.1% | -42.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -88.2% | -28.6% |
| Volatility (annualized) | 136.2% | 132.5% |
| Max drawdown | -92.0% (Jan 2026→Oct 2026) | -93.5% (Aug 2025→Oct 2026) |

## Peers (Medical Instruments & Supplies)
KMTS (Kestra Medical Technologies, Lt) USD 28.68 +6.34% · XRAY (DENTSPLY SIRONA Inc.) USD 8.83 +3.76% · LMAT (LeMaitre Vascular, Inc.) USD 83.16 +1.97% · ATRC (AtriCure, Inc.) USD 57.78 +1.60% · WRBY (Warby Parker Inc.) USD 24.59 -7.28% · PLSE (Pulse Biosciences, Inc) USD 45.59 -6.08%

## More
Full page: https://nexqual.com/NNNN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt